These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. [Fatty acid composition of liver lipids in chronic hepatitis, liver cirrhosis and fatty liver]. Mokhov VM, Bliuzdin IuA. Vopr Med Khim; 1987 Dec 31; 33(3):38-42. PubMed ID: 3630012 [Abstract] [Full Text] [Related]
30. Insulin resistance and metabolic syndrome in chronic liver diseases: old entities with new implications. Tsochatzis EA, Manolakopoulos S, Papatheodoridis GV, Archimandritis AJ. Scand J Gastroenterol; 2009 Dec 31; 44(1):6-14. PubMed ID: 18661429 [Abstract] [Full Text] [Related]
31. [Place of echography in the differential diagnosis of portal hypertension in cirrhosis and other diseases of the liver]. Brailski Kh, Grigorov N, Glavincheva I, Etŭrska M, Popov P. Vutr Boles; 1984 Dec 31; 23(5):34-42. PubMed ID: 6395492 [No Abstract] [Full Text] [Related]
35. Hepatic metabolism of estrogens in health and disease. Adlercreutz H. N Engl J Med; 1974 May 09; 290(19):1081-3. PubMed ID: 4362572 [No Abstract] [Full Text] [Related]
36. A simple method for routine determination of the metabolic liver capacity: the aminopyrine breath test. Haustein KO, Schenker E. Int J Clin Pharmacol Ther Toxicol; 1985 Apr 09; 23(4):190-6. PubMed ID: 3922902 [Abstract] [Full Text] [Related]
38. Essential fatty acid status in infants and children with chronic liver disease. Abdel-Ghaffar YT, Amin E, Abdel-Rasheed M, Fouad HH. East Mediterr Health J; 2003 Apr 09; 9(1-2):61-9. PubMed ID: 15562734 [Abstract] [Full Text] [Related]